Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.440
-0.004 (-0.90%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cognition Therapeutics Employees
As of December 31, 2023, Cognition Therapeutics had 28 total employees, including 25 full-time and 3 part-time employees. The number of employees increased by 3 or 12.00% compared to the previous year.
Employees
28
Change (1Y)
3
Growth (1Y)
12.00%
Revenue / Employee
n/a
Profits / Employee
-$1,223,929
Market Cap
17.66M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28 | 3 | 12.00% |
Dec 31, 2022 | 25 | 4 | 19.05% |
Dec 31, 2021 | 21 | 1 | 5.00% |
Dec 31, 2020 | 20 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Retractable Technologies | 151 |
ProPhase Labs | 113 |
Flora Growth | 108 |
bioAffinity Technologies | 75 |
Apollomics | 45 |
Palatin Technologies | 30 |
MEI Pharma | 28 |
Akari Therapeutics, | 12 |
CGTX News
- 8 days ago - Cognition Therapeutics Reports Financial Results for the Third Quarter 2024 and Provides Business and Clinical Update - GlobeNewsWire
- 9 days ago - Cognition Therapeutics to Present at Zacks SCR Life Sciences Investor Forum - GlobeNewsWire
- 20 days ago - Cognition Therapeutics Presents Poster of Participant Demographics from Phase 2 Dementia with Lewy Bodies Study at CTAD - GlobeNewsWire
- 22 days ago - Cognition Therapeutics Announces Results of Pre-specified Analysis of SHINE Study Data Presented at CTAD - GlobeNewsWire
- 4 weeks ago - Analyses from Cognition's Positive Phase 2 ‘SHINE' Study of CT1812 in Mild-to-Moderate Alzheimer's Disease will be Presented in a Podium Presentation at CTAD - GlobeNewsWire
- 4 weeks ago - Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Executing Clinical Research in Dementia with Lewy Bodies (DLB) - GlobeNewsWire
- 7 weeks ago - Cognition Therapeutics Will Participate in the Roth Healthcare Opportunities Conference - GlobeNewsWire
- 7 weeks ago - Cognition Therapeutics Supports Lewy Body Dementia Awareness Month and the Need for Improved Treatments for the Second Most Common Dementia - GlobeNewsWire